Search Results for "outcome assessment"

Tom Caravela

Interview Differentiator-Be a Story Teller

Mar 22^nd • 1 min read

Tom Caravela

“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders

Jul 9^th • 1 min read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

10 Ways to Make an Impact on a Phone Interview

Apr 9^th • 1 min read

Tom Caravela

7 High-Cost Interview Mistakes that are Easy to Avoid

Jul 28^th • 1 min read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 5^th • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%

Sep 3^rd • 1 min read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Apr 20^th • 8 mins read

Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Apr 7^th • 12 mins read

Adela Rodriguez, Francis Esposito, Helena Oliveres, Ferran Torres and Joan Maurel

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

Feb 11^th • 3 mins read

Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22^nd • 10 mins read

Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Feb 11^th • 4 mins read

Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Nov 20^th • 12 mins read

J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Sep 26^th • 17 mins read

E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Sep 21^st • 3 mins read

Yuan Zhang, Xu Liu, Ying-Qin Li, Ling-Long Tang, Lei Chen, Jun Ma

A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure

Aug 12^th • 10 mins read

Shani Paluch-Shimon, Nathan I. Cherny, Elisabeth G.E. de Vries, Urania Dafni, Martine J. Piccart, Nicola Jane Latino, Fatima Cardoso

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Sep 6^th • 20 mins read

Fei Liang, Sheng Zhang, Qin Wang, Wenfeng Li

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Aug 31^st • 16 mins read

Navigation

Results for 'outcome assessment'

Interview Differentiator-Be a Story Teller

“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders

Job Search Checklist for Aspiring Medical Science Liaisons

10 Ways to Make an Impact on a Phone Interview

7 High-Cost Interview Mistakes that are Easy to Avoid

MSL Evolution: New Trends and Titles That May Emerge

MSL People Skills: Top 10 Tips for Better Engagement

Clinical Educator Oncology Program Improves Adherence by 29%

Transforming oncology: Five frontiers driving progress in cancer care

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Leveraging existing data to contextualize phase II clinical trial findings in oncology

A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Related Topics

Navigation

Results for 'outcome assessment'

Interview Differentiator-Be a Story Teller

“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders

Job Search Checklist for Aspiring Medical Science Liaisons

10 Ways to Make an Impact on a Phone Interview

7 High-Cost Interview Mistakes that are Easy to Avoid

MSL Evolution: New Trends and Titles That May Emerge

MSL People Skills: Top 10 Tips for Better Engagement

Clinical Educator Oncology Program Improves Adherence by 29%​

Transforming oncology: Five frontiers driving progress in cancer care

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Leveraging existing data to contextualize phase II clinical trial findings in oncology

A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Related Topics

Clinical Educator Oncology Program Improves Adherence by 29%